Moderna is facing criticism for refusing to share its COVID-19 vaccine formula amid global vaccine shortages and continuing COVID-19 vaccine inequities. As one of two successful mRNA vaccines against COVID-19, along with Pfizer/BioNTech’s vaccine, pressure has been mounting on the vaccine maker to accelerate production and delivery of its shots to countries that are lagging behind in vaccinations over issues of availability and access.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,